UK Medtechs' Brexit Readiness Moves Up A Notch In Absence Of EU Deal Framework
Executive Summary
The UK is unmistakeably in the period of the calm before the storm, and an enforced Brexit lull is in place. But the thoughts of UK and EU decision-makers – and UK medtech companies – are not straying too far from the upcoming trade deal negotiations and the business of making the best of Brexit, however and whenever it manifests itself.
You may also be interested in...
UK MHRA Makes Statements On Brexit Implementation Period – But On Shaky Ground?
The UK and EU27 medtech industries are desperate for information about what to do to prepare for Brexit. The UK medtech regulator has issued documents that might give insight, but there are still no certainties on the horizon.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.